A previous study has shown that ciRS-7, which is downregulated in the brain of AD patients [469], attenuates generation of Aβ-peptide in neurons by promoting the degradation of APP and β-site APP cleaving enzyme-1 (BACE1) protein in a NF-κB-dependent manner [340]. Here, NFKB1 is linked to Alzheimer disease.